These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8053717)

  • 1. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.
    Nordlund JJ; Kirkwood J; Forget BM; Scheibner A; Albert DM; Lerner E; Milton GW
    Cancer Res; 1985 Apr; 45(4):1855-61. PubMed ID: 3978645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.
    Carli P; Balzi D; de Giorgi V; Massi D; Palli D; Chiarugi A; Nardini P; Giannotti B
    Eur J Dermatol; 2003; 13(5):482-6. PubMed ID: 14693495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
    Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
    Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic vulvar nevi.
    Blickstein I; Feldberg E; Dgani R; Ben-Hur H; Czernobilsky B
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):968-70. PubMed ID: 1923241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients.
    de Snoo FA; Kroon MW; Bergman W; ter Huurne JA; Houwing-Duistermaat JJ; van Mourik L; Snels DG; Breuning MH; Willemze R; Frants RR; Gruis NA
    J Am Acad Dermatol; 2007 May; 56(5):748-52. PubMed ID: 17276542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
    Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
    J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic spectrum of clinically atypical melanocytic nevi. II. Studies of nonfamilial melanoma.
    Barnhill RL; Roush GC
    Arch Dermatol; 1990 Oct; 126(10):1315-8. PubMed ID: 2221935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].
    Bergman W; van Voorst Vader PC; Ruiter DJ
    Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2010-4. PubMed ID: 9550752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined melanocytic nevi: histologic variants and melanoma mimics.
    Baran JL; Duncan LM
    Am J Surg Pathol; 2011 Oct; 35(10):1540-8. PubMed ID: 21881487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
    Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
    Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
    Szekeres L; Korom I
    Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading of atypia in nevi: correlation with melanoma risk.
    Arumi-Uria M; McNutt NS; Finnerty B
    Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.